News
ANGO
10.56
+4.97%
0.50
AngioDynamics (ANGO) Down 3.9% Since Last Earnings Report: Can It Rebound?
NASDAQ · 1d ago
AngioDynamics und The PERT Consortium gründen Forschungsfonds für Lungenembolie
Reuters · 1d ago
AngioDynamics and PERT Consortium Launch Investigator-Led Pulmonary Embolism Research Fund
Reuters · 1d ago
AngioDynamics announces CEO transition and leadership retention plan
TipRanks · 3d ago
AngioDynamics Announces CEO Retirement Agreement and Executive Retention Bonuses
Reuters · 3d ago
AngioDynamics legt neue Vergütungs- und Retentionsvereinbarungen für Führungskräfte fest
Reuters · 3d ago
AngioDynamics Secures FDA IDE Approval and Expanded 510(k) Clearance for AlphaVac System
Reuters · 3d ago
FDA genehmigt IDE-Antrag von AngioDynamics für APEX-Return-Studie
Reuters · 3d ago
Weekly Report: what happened at ANGO last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at ANGO last week (0119-0123)?
Weekly Report · 01/26 09:07
Weekly Report: what happened at ANGO last week (0112-0116)?
Weekly Report · 01/19 09:08
AngioDynamics Inc. Highlights Growth Strategy and Innovation in Cardiovascular and Cancer Markets
Reuters · 01/14 22:34
The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic
NASDAQ · 01/14 15:13
AngioDynamics Highlights Growth Strategy at J.P. Morgan Conference
TipRanks · 01/14 12:58
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts
NASDAQ · 01/13 18:40
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)
NASDAQ · 01/12 14:35
Weekly Report: what happened at ANGO last week (0105-0109)?
Weekly Report · 01/12 09:08
Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum
Simply Wall St · 01/09 17:20
AngioDynamics: Operational Outperformance, Raised FY2026 Outlook, and Advancing Clinical Pipeline Support Buy Rating and $16 Target
TipRanks · 01/07 17:05
Analysts Have Conflicting Sentiments on These Healthcare Companies: Perspective Therapeutics (CATX), Warby Parker (WRBY) and AngioDynamics (ANGO)
TipRanks · 01/07 12:20
More
Webull provides a variety of real-time ANGO stock news. You can receive the latest news about Angiodynamics through multiple platforms. This information may help you make smarter investment decisions.
About ANGO
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.